Neuropsychiatric manifestations of Kufs disease. [PDF]
Vijayan S, Selvaraj A.
europepmc +1 more source
Neuronal Ceroid Lipofuscinosis-Concepts, Classification, and Avenues for Therapy. [PDF]
Zhang Y, Du B, Zou M, Peng B, Rao Y.
europepmc +1 more source
Trends in the Engineering of Adeno-Associated Virus (AAV) for Precision Gene Delivery to the Central Nervous System (CNS). [PDF]
Oloruntimehin S, Malogolovkin A.
europepmc +1 more source
Neuronal ceroid lipofuscinosis: underlying mechanisms and emerging therapeutic targets. [PDF]
Ziółkowska EA +5 more
europepmc +1 more source
Psychiatric manifestations in Neuronal ceroid lipofuscinoses. [PDF]
Della Vecchia S +5 more
europepmc +1 more source
Iatrogenic cerebral amyloid angiopathy 30 years after childhood cadaveric dura mater transplantation: a case report. [PDF]
Takai I +13 more
europepmc +1 more source
Pediatric onset neuronal ceroid lipofuscinoses: Unraveling clinical and genetic specifications. [PDF]
Ahdi SG, Alvi JR, Ashfaq A, Sultan T.
europepmc +1 more source
Medicinally Tuned Pyrimidine-Oxadiazole Hybrids: Synthetic Development, Enzyme-Targeted Evaluation, In Vivo Toxicological Assessment and Computational Investigations Against Diabetes Mellitus. [PDF]
Felemban S, Khowdiary MM.
europepmc +1 more source
(<i>E</i>)-2,4-Di-amino-5-{7-[(4-chloro-phen-yl)diazen-yl]-3,3-dimethyl-1-oxo-2,3,4,9-tetra-hydro-1<i>H</i>-xanthen-9-yl}-6-oxo-1,6-di-hydro-pyridine-3-carbo-nitrile di-methyl-formamide monosolvate. [PDF]
Elgemeie GH +3 more
europepmc +1 more source
A Contemporary Pathomechanistic Nosology of Inherited Lysosomal Disorders. [PDF]
McCarron EP +7 more
europepmc +1 more source

